<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37374237</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1648-9144</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>26</Day></PubDate></JournalIssue><Title>Medicina (Kaunas, Lithuania)</Title><ISOAbbreviation>Medicina (Kaunas)</ISOAbbreviation></Journal><ArticleTitle>Disentangling the Pathogenesis of Systemic Lupus Erythematosus: Close Ties between Immunological, Genetic and Environmental Factors.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1033</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/medicina59061033</ELocationID><Abstract><AbstractText>Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disease that attacks various organ systems with a variety of clinical implications, ranging from mild skin and mucosal manifestations to severe central nervous system manifestations and death. Cases of SLE have been documented nearly two centuries ago when scholars used the terms 'erythema centrifugum' and 'seborrhea congestiva' to describe the discoid skin lesions and the butterfly or malar rash in SLE. Since then, knowledge about this disease has developed rapidly, especially knowledge related to the underlying pathogenesis of SLE. To date, it is known that immune system dysregulation, supported by genetic and environmental predisposition, can trigger the occurrence of SLE in a group of susceptible individuals. Various inflammatory mediators, cytokines and chemokines, as well as intra- and intercellular signaling pathways, are involved in the pathogenesis of SLE. In this review, we will discuss the molecular and cellular aspects of SLE pathogenesis, with a focus on how the immune system, genetics and the environment interact and trigger the various clinical manifestations of SLE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sutanto</LastName><ForeName>Henry</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-5730-2013</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya 60132, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Dr. Soetomo General Academic Hospital, Surabaya 60286, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuliasih</LastName><ForeName>Yuliasih</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya 60132, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Dr. Soetomo General Academic Hospital, Surabaya 60286, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya 60132, Indonesia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Medicina (Kaunas)</MedlineTA><NlmUniqueID>9425208</NlmUniqueID><ISSNLinking>1010-660X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000721270">malar rash</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012871" MajorTopicYN="Y">Skin Diseases</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autoimmune</Keyword><Keyword MajorTopicYN="N">environment</Keyword><Keyword MajorTopicYN="N">genetics</Keyword><Keyword MajorTopicYN="N">immune</Keyword><Keyword MajorTopicYN="N">internal medicine</Keyword><Keyword MajorTopicYN="N">rheumatic disease</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37374237</ArticleId><ArticleId IdType="pmc">PMC10305227</ArticleId><ArticleId IdType="doi">10.3390/medicina59061033</ArticleId><ArticleId IdType="pii">medicina59061033</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Justiz Vaillant A.A., Goyal A., Varacallo M. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2022. Systemic Lupus Erythematosus.</Citation><ArticleIdList><ArticleId IdType="pubmed">30571026</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J., Zhang D., Yao X., Huang Y., Lu Q. Global Epidemiology of Systemic Lupus Erythematosus: A Comprehensive Systematic Analysis and Modelling Study. Ann. Rheum. Dis. 2022;82:351&#x2013;356. doi: 10.1136/ard-2022-223035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard-2022-223035</ArticleId><ArticleId IdType="pmc">PMC9933169</ArticleId><ArticleId IdType="pubmed">36241363</ArticleId></ArticleIdList></Reference><Reference><Citation>Weckerle C.E., Niewold T.B. The Unexplained Female Predominance of Systemic Lupus Erythematosus: Clues from Genetic and Cytokine Studies. Clin. Rev. Allergy Immunol. 2011;40:42&#x2013;49. doi: 10.1007/s12016-009-8192-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-009-8192-4</ArticleId><ArticleId IdType="pmc">PMC2891868</ArticleId><ArticleId IdType="pubmed">20063186</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas R., Jawad A.S. Systemic Lupus Erythematosus: Rarer in Men than Women but More Severe. Trends Urol. Men&#x2019;s Health. 2022;13:11&#x2013;14. doi: 10.1002/tre.876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/tre.876</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuliasih Y. Perkembangan Patogenesis Dan Tata Laksana Systemic Lupus Erythematosus. Airlangga University Press; Surabaya, Indonesia: 2020.</Citation></Reference><Reference><Citation>Cervera R., Khamashta M.A., Font J., Sebastiani G.D., Gil A., Lavilla P., Mej&#xed;a J.C., Aydintug A.O., Chwalinska-Sadowska H., de Ram&#xf3;n E., et al. Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period: A Comparison of Early and Late Manifestations in a Cohort of 1000 Patients. Medicine. 2003;82:299. doi: 10.1097/01.md.0000091181.93122.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.md.0000091181.93122.55</ArticleId><ArticleId IdType="pubmed">14530779</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber M.R.W., Drenkard C., Falasinnu T., Hoi A., Mak A., Kow N.Y., Svenungsson E., Peterson J., Clarke A.E., Ramsey-Goldman R. Global Epidemiology of Systemic Lupus Erythematosus. Nat. Rev. Rheumatol. 2021;17:515&#x2013;532. doi: 10.1038/s41584-021-00668-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00668-1</ArticleId><ArticleId IdType="pmc">PMC8982275</ArticleId><ArticleId IdType="pubmed">34345022</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R.R., Yen E.Y. SLE Mortality Remains Disproportionately High, despite Improvements over the Last Decade. Lupus. 2018;27:1577&#x2013;1581. doi: 10.1177/0961203318786436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203318786436</ArticleId><ArticleId IdType="pmc">PMC6082727</ArticleId><ArticleId IdType="pubmed">30016928</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocampo-Piraquive V., Nieto-Aristiz&#xe1;bal I., Ca&#xf1;as C.A., Tob&#xf3;n G.J. Mortality in Systemic Lupus Erythematosus: Causes, Predictors and Interventions. Expert Rev. Clin. Immunol. 2018;14:1043&#x2013;1053. doi: 10.1080/1744666X.2018.1538789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2018.1538789</ArticleId><ArticleId IdType="pubmed">30338717</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith C.D., Cyr M. The History of Lupus Erythematosus. From Hippocrates to Osler. Rheum. Dis. Clin. N. Am. 1988;14:1&#x2013;14. doi: 10.1016/S0889-857X(21)00942-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0889-857X(21)00942-X</ArticleId><ArticleId IdType="pubmed">3041483</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark D.N., Poole B.D., Clark D.N., Poole B.D. Interferon and Apoptosis in Systemic Lupus Erythematosus. IntechOpen; London, UK: 2012.</Citation></Reference><Reference><Citation>Li D., Wu M. Pattern Recognition Receptors in Health and Diseases. Sig. Transduct. Target Ther. 2021;6:291. doi: 10.1038/s41392-021-00687-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00687-0</ArticleId><ArticleId IdType="pmc">PMC8333067</ArticleId><ArticleId IdType="pubmed">34344870</ArticleId></ArticleIdList></Reference><Reference><Citation>Psarras A., Alase A., Antanaviciute A., Carr I.M., Md Yusof M.Y., Wittmann M., Emery P., Tsokos G.C., Vital E.M. Functionally Impaired Plasmacytoid Dendritic Cells and Non-Haematopoietic Sources of Type I Interferon Characterize Human Autoimmunity. Nat. Commun. 2020;11:6149. doi: 10.1038/s41467-020-19918-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19918-z</ArticleId><ArticleId IdType="pmc">PMC7708979</ArticleId><ArticleId IdType="pubmed">33262343</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C.-F., Peng W.-M., Oldenburg J., Hoch J., Bieber T., Limmer A., Hartmann G., Barchet W., Eis-H&#xfc;binger A.M., Novak N. Human Plasmacytoid Dendritic Cells Support Th17 Cell Effector Function in Response to TLR7 Ligation. J. Immunol. 2010;184:1159&#x2013;1167. doi: 10.4049/jimmunol.0901706.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0901706</ArticleId><ArticleId IdType="pubmed">20026744</ArticleId></ArticleIdList></Reference><Reference><Citation>Ameer M.A., Chaudhry H., Mushtaq J., Khan O.S., Babar M., Hashim T., Zeb S., Tariq M.A., Patlolla S.R., Ali J., et al. An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management. Cureus. 2022;14:e30330. doi: 10.7759/cureus.30330.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.30330</ArticleId><ArticleId IdType="pmc">PMC9662848</ArticleId><ArticleId IdType="pubmed">36407159</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow M.K. Pathogenesis of Systemic Lupus Erythematosus: Risks, Mechanisms and Therapeutic Targets. Ann. Rheum. Dis. 2023 doi: 10.1136/ard-2022-223741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard-2022-223741</ArticleId><ArticleId IdType="pubmed">36792346</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L., Lu M.-P., Wang J.-H., Xu M., Yang S.-R. Immunological Pathogenesis and Treatment of Systemic Lupus Erythematosus. World J. Pediatr. 2020;16:19&#x2013;30. doi: 10.1007/s12519-019-00229-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-019-00229-3</ArticleId><ArticleId IdType="pmc">PMC7040062</ArticleId><ArticleId IdType="pubmed">30796732</ArticleId></ArticleIdList></Reference><Reference><Citation>Sifuentes Giraldo W.A., Garc&#xed;a Villanueva M.J., Boteanu A.L., Lois Iglesias A., Zea Mendoza A.C. New Therapeutic Targets in Systemic Lupus. Reumatol. Cl&#xed;nica (Engl. Ed.) 2012;8:201&#x2013;207. doi: 10.1016/j.reumae.2012.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reumae.2012.06.011</ArticleId><ArticleId IdType="pubmed">22483661</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Cao S.-Q., Lin Z.-M., He S.-J., Zuo J.-P. NOD-like Receptors in Autoimmune Diseases. Acta Pharmacol. Sin. 2021;42:1742&#x2013;1756. doi: 10.1038/s41401-020-00603-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-020-00603-2</ArticleId><ArticleId IdType="pmc">PMC8564530</ArticleId><ArticleId IdType="pubmed">33589796</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieterse E., van der Vlag J. Breaking Immunological Tolerance in Systemic Lupus Erythematosus. Front Immunol. 2014;5:164. doi: 10.3389/fimmu.2014.00164.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00164</ArticleId><ArticleId IdType="pmc">PMC3988363</ArticleId><ArticleId IdType="pubmed">24782867</ArticleId></ArticleIdList></Reference><Reference><Citation>Salemme R., Peralta L.N., Meka S.H., Pushpanathan N., Alexander J.J. The Role of NETosis in Systemic Lupus Erythematosus. J. Cell. Immunol. 2019;1:33&#x2013;42. doi: 10.33696/immunology.1.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.33696/immunology.1.008</ArticleId><ArticleId IdType="pmc">PMC6980316</ArticleId><ArticleId IdType="pubmed">31984378</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes M. Immune Tolerance: Mechanisms and Application in Clinical Transplantation. J. Intern. Med. 2007;262:288&#x2013;310. doi: 10.1111/j.1365-2796.2007.01855.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2007.01855.x</ArticleId><ArticleId IdType="pubmed">17697153</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan M.J., Lewis E.E., Shelden E.A., Somers E., Pavlic R., McCune W.J., Richardson B.C. The Apoptotic Ligands TRAIL, TWEAK, and Fas Ligand Mediate Monocyte Death Induced by Autologous Lupus T Cells. J. Immunol. 2002;169:6020&#x2013;6029. doi: 10.4049/jimmunol.169.10.6020.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.169.10.6020</ArticleId><ArticleId IdType="pubmed">12421989</ArticleId></ArticleIdList></Reference><Reference><Citation>Koga T., Ichinose K., Kawakami A., Tsokos G.C. Current Insights and Future Prospects for Targeting IL-17 to Treat Patients With Systemic Lupus Erythematosus. Front. Immunol. 2021;11:624971. doi: 10.3389/fimmu.2020.624971.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.624971</ArticleId><ArticleId IdType="pmc">PMC7882681</ArticleId><ArticleId IdType="pubmed">33597953</ArticleId></ArticleIdList></Reference><Reference><Citation>Piantoni S., Andreoli L., Scarsi M., Zanola A., Dall&#x2019;Ara F., Pizzorni C., Cutolo M., Air&#xf2; P., Tincani A. Phenotype Modifications of T-Cells and Their Shift toward a Th2 Response in Patients with Systemic Lupus Erythematosus Supplemented with Different Monthly Regimens of Vitamin D. Lupus. 2015;24:490&#x2013;498. doi: 10.1177/0961203314559090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314559090</ArticleId><ArticleId IdType="pubmed">25801892</ArticleId></ArticleIdList></Reference><Reference><Citation>Talaat R.M., Mohamed S.F., Bassyouni I.H., Raouf A.A. Th1/Th2/Th17/Treg Cytokine Imbalance in Systemic Lupus Erythematosus (SLE) Patients: Correlation with Disease Activity. Cytokine. 2015;72:146&#x2013;153. doi: 10.1016/j.cyto.2014.12.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2014.12.027</ArticleId><ArticleId IdType="pubmed">25647269</ArticleId></ArticleIdList></Reference><Reference><Citation>Akahoshi M., Nakashima H., Tanaka Y., Kohsaka T., Nagano S., Ohgami E., Arinobu Y., Yamaoka K., Niiro H., Shinozaki M., et al. Th1/Th2 Balance of Peripheral T Helper Cells in Systemic Lupus Erythematosus. Arthritis Rheumatol. 1999;42:1644&#x2013;1648. doi: 10.1002/1529-0131(199908)42:8&lt;1644::AID-ANR12&gt;3.0.CO;2-L.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(199908)42:8&lt;1644::AID-ANR12&gt;3.0.CO;2-L</ArticleId><ArticleId IdType="pubmed">10446863</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan R.W.-Y., Lai F.M.-M., Li E.K.-M., Tam L.-S., Chow K.-M., Li P.K.-T., Szeto C.-C. Imbalance of Th1/Th2 Transcription Factors in Patients with Lupus Nephritis. Rheumatology. 2006;45:951&#x2013;957. doi: 10.1093/rheumatology/kel029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kel029</ArticleId><ArticleId IdType="pubmed">16461436</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolff S., Bijl M., Huitema M.G., Limburg P.C., Kallenberg C.G.M., Abdulahad W.H. Disturbed Th1, Th2, Th17 and T(Reg) Balance in Patients with Systemic Lupus Erythematosus. Clin. Immunol. 2011;141:197&#x2013;204. doi: 10.1016/j.clim.2011.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2011.08.005</ArticleId><ArticleId IdType="pubmed">21920821</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuliasih Y., Diah Rahmawati L., Maulidya Putri R. Ratio of Th17/Treg and Disease Activity in Systemic Lupus Erythematosus. Caspian J. Intern. Med. 2019;10:65&#x2013;72. doi: 10.22088/cjim.10.1.65.</Citation><ArticleIdList><ArticleId IdType="doi">10.22088/cjim.10.1.65</ArticleId><ArticleId IdType="pmc">PMC6386323</ArticleId><ArticleId IdType="pubmed">30858943</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhammad Yusoff F., Wong K.K., Mohd Redzwan N. Th1, Th2, and Th17 Cytokines in Systemic Lupus Erythematosus. Autoimmunity. 2020;53:8&#x2013;20. doi: 10.1080/08916934.2019.1693545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916934.2019.1693545</ArticleId><ArticleId IdType="pubmed">31771364</ArticleId></ArticleIdList></Reference><Reference><Citation>Catal&#xe1;n D., Mansilla M.A., Ferrier A., Soto L., Oleinika K., Aguill&#xf3;n J.C., Aravena O. Immunosuppressive Mechanisms of Regulatory B Cells. Front. Immunol. 2021;12:611795. doi: 10.3389/fimmu.2021.611795.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.611795</ArticleId><ArticleId IdType="pmc">PMC8118522</ArticleId><ArticleId IdType="pubmed">33995344</ArticleId></ArticleIdList></Reference><Reference><Citation>Karrar S., Cunninghame Graham D.S. Abnormal B Cell Development in Systemic Lupus Erythematosus. Arthritis Rheumatol. 2018;70:496&#x2013;507. doi: 10.1002/art.40396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40396</ArticleId><ArticleId IdType="pmc">PMC5900717</ArticleId><ArticleId IdType="pubmed">29207444</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap D.Y.H., Chan T.M. B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis&#x2014;Role in Pathogenesis and Effect of Immunosuppressive Treatments. Int. J. Mol. Sci. 2019;20:6231. doi: 10.3390/ijms20246231.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20246231</ArticleId><ArticleId IdType="pmc">PMC6940927</ArticleId><ArticleId IdType="pubmed">31835612</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosaad Y.M. Clinical Role of Human Leukocyte Antigen in Health and Disease. Scand. J. Immunol. 2015;82:283&#x2013;306. doi: 10.1111/sji.12329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12329</ArticleId><ArticleId IdType="pubmed">26099424</ArticleId></ArticleIdList></Reference><Reference><Citation>Dedhia L., Pradhan V., Ghosh K., Nadkar M., Parekh S. Association of Human Leucocyte Antigen (HLA) Class II with Systemic Lupus Erythematosis (SLE) Patients from Western India. Meta Gene. 2018;16:230&#x2013;233. doi: 10.1016/j.mgene.2018.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mgene.2018.03.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Gallo L.-M., Oke V., Lundstr&#xf6;m E., Elvin K., Ling Wu Y., Eketj&#xe4;ll S., Zickert A., Gustafsson J.T., J&#xf6;nsen A., Leonard D., et al. Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA-DRB1 Genotype Associations and Immunological and Clinical Manifestations. ACR Open Rheumatol. 2022;4:27&#x2013;39. doi: 10.1002/acr2.11343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr2.11343</ArticleId><ArticleId IdType="pmc">PMC8754019</ArticleId><ArticleId IdType="pubmed">34658170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon Y.-C., Chun S., Kim K., Mak A. Update on the Genetics of Systemic Lupus Erythematosus: Genome-Wide Association Studies and Beyond. Cells. 2019;8:1180. doi: 10.3390/cells8101180.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8101180</ArticleId><ArticleId IdType="pmc">PMC6829439</ArticleId><ArticleId IdType="pubmed">31575058</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K., Bang S.-Y., Lee H.-S., Okada Y., Han B., Saw W.-Y., Teo Y.-Y., Bae S.-C. The HLA-DR&#x3b2;1 Amino Acid Positions 11-13-26 Explain the Majority of SLE-MHC Associations. Nat. Commun. 2014;5:5902. doi: 10.1038/ncomms6902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6902</ArticleId><ArticleId IdType="pubmed">25533202</ArticleId></ArticleIdList></Reference><Reference><Citation>Molineros J.E., Looger L.L., Kim K., Okada Y., Terao C., Sun C., Zhou X.-J., Raj P., Kochi Y., Suzuki A., et al. Amino Acid Signatures of HLA Class-I and II Molecules Are Strongly Associated with SLE Susceptibility and Autoantibody Production in Eastern Asians. PLoS Genet. 2019;15:e1008092. doi: 10.1371/journal.pgen.1008092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1008092</ArticleId><ArticleId IdType="pmc">PMC6504188</ArticleId><ArticleId IdType="pubmed">31022184</ArticleId></ArticleIdList></Reference><Reference><Citation>Terao C., Ohmura K., Yamada R., Kawaguchi T., Shimizu M., Tabara Y., Takahashi M., Setoh K., Nakayama T., Kosugi S., et al. Association Between Antinuclear Antibodies and the HLA Class II Locus and Heterogeneous Characteristics of Staining Patterns: The Nagahama Study. Arthritis Rheumatol. 2014;66:3395&#x2013;3403. doi: 10.1002/art.38867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38867</ArticleId><ArticleId IdType="pubmed">25186300</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain N., Jaffery G., Sabri A.N., Hasnain S. HLA Association in SLE Patients from Lahore-Pakistan. Bosn. J. Basic Med. Sci. 2011;11:20&#x2013;26. doi: 10.17305/bjbms.2011.2618.</Citation><ArticleIdList><ArticleId IdType="doi">10.17305/bjbms.2011.2618</ArticleId><ArticleId IdType="pmc">PMC4362559</ArticleId><ArticleId IdType="pubmed">21342137</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvaraja M., Chin V.K., Abdullah M., Arip M., Amin-Nordin S. HLA-DRB1*04 as a Risk Allele to Systemic Lupus Erythematosus and Lupus Nephritis in the Malay Population of Malaysia. Front. Med. 2021;7:598665. doi: 10.3389/fmed.2020.598665.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.598665</ArticleId><ArticleId IdType="pmc">PMC7902771</ArticleId><ArticleId IdType="pubmed">33644084</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadi W., Elhefny N.e.A.M., Mahgoub E.H., Almogren A., Hamam K.D., Al&#x2013;hamed H.A., Gasim G.I. Relation between HLA Typing and Clinical Presentations in Systemic Lupus Erythematosus Patients in Al-Qassim Region, Saudi Arabia. Int. J. Health Sci. (Qassim) 2014;8:159&#x2013;165. doi: 10.12816/0006082.</Citation><ArticleIdList><ArticleId IdType="doi">10.12816/0006082</ArticleId><ArticleId IdType="pmc">PMC4166988</ArticleId><ArticleId IdType="pubmed">25246883</ArticleId></ArticleIdList></Reference><Reference><Citation>Reveille J.D., Moulds J.M., Ahn C., Friedman A.W., Baethge B., Roseman J., Straaton K.V., Alarc&#xf3;n G.S. Systemic Lupus Erythematosus in Three Ethnic Groups: I. The Effects of HLA Class II, C4, and CR1 Alleles, Socioeconomic Factors, and Ethnicity at Disease Onset. LUMINA Study Group. Lupus in Minority Populations, Nature versus Nurture. Arthritis Rheumatol. 1998;41:1161&#x2013;1172. doi: 10.1002/1529-0131(199807)41:7&lt;1161::AID-ART4&gt;3.0.CO;2-K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(199807)41:7&lt;1161::AID-ART4&gt;3.0.CO;2-K</ArticleId><ArticleId IdType="pubmed">9663471</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Yang Y., Upreti B., Liu S., Cui R., Cheng Y., Tao L., Dong J., Li L., Xu J. Association between HLA-B and HLA-DRB1 Polymorphisms and Systemic Lupus Erythematosus in Han Population in China. Rheumatol. Autoimmun. 2022;2:31&#x2013;39. doi: 10.1002/rai2.12023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rai2.12023</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul A., Gordon C., Crow M.K., Touma Z., Urowitz M.B., van Vollenhoven R., Ruiz-Irastorza G., Hughes G. Systemic Lupus Erythematosus. Nat. Rev. Dis. Prim. 2016;2:16039. doi: 10.1038/nrdp.2016.39.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2016.39</ArticleId><ArticleId IdType="pubmed">27306639</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown G.J., Ca&#xf1;ete P.F., Wang H., Medhavy A., Bones J., Roco J.A., He Y., Qin Y., Cappello J., Ellyard J.I., et al. TLR7 Gain-of-Function Genetic Variation Causes Human Lupus. Nature. 2022;605:349&#x2013;356. doi: 10.1038/s41586-022-04642-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04642-z</ArticleId><ArticleId IdType="pmc">PMC9095492</ArticleId><ArticleId IdType="pubmed">35477763</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.-F., Zhang Y., Lin Z., Zhang H., Wang T.-Y., Cao Y., Morris D.L., Sheng Y., Yin X., Zhong S.-L., et al. Identification of 38 Novel Loci for Systemic Lupus Erythematosus and Genetic Heterogeneity between Ancestral Groups. Nat. Commun. 2021;12:772. doi: 10.1038/s41467-021-21049-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21049-y</ArticleId><ArticleId IdType="pmc">PMC7858632</ArticleId><ArticleId IdType="pubmed">33536424</ArticleId></ArticleIdList></Reference><Reference><Citation>Elghzaly A.A., Sun C., Looger L.L., Hirose M., Salama M., Khalil N.M., Behiry M.E., Hegazy M.T., Hussein M.A., Salem M.N., et al. Genome-Wide Association Study for Systemic Lupus Erythematosus in an Egyptian Population. Front. Genet. 2022;13:948505. doi: 10.3389/fgene.2022.948505.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2022.948505</ArticleId><ArticleId IdType="pmc">PMC9619055</ArticleId><ArticleId IdType="pubmed">36324510</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X., Kim K., Suetsugu H., Bang S.-Y., Wen L., Koido M., Ha E., Liu L., Sakamoto Y., Jo S., et al. Meta-Analysis of 208370 East Asians Identifies 113 Susceptibility Loci for Systemic Lupus Erythematosus. Ann. Rheum. Dis. 2021;80:632&#x2013;640. doi: 10.1136/annrheumdis-2020-219209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-219209</ArticleId><ArticleId IdType="pmc">PMC8053352</ArticleId><ArticleId IdType="pubmed">33272962</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseini A., Gharibi T., Marofi F., Babaloo Z., Baradaran B. CTLA-4: From Mechanism to Autoimmune Therapy. Int. Immunopharmacol. 2020;80:106221. doi: 10.1016/j.intimp.2020.106221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.106221</ArticleId><ArticleId IdType="pubmed">32007707</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;cker H., Tseng P.-H., Karin M. Expanding TRAF Function: TRAF3 as a Tri-Faced Immune Regulator. Nat. Rev. Immunol. 2011;11:457&#x2013;468. doi: 10.1038/nri2998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2998</ArticleId><ArticleId IdType="pubmed">21660053</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Q., Liu Z., Liao S., Ye L., Lu X., Chen X., Li Z., Li X., Xu Y.-Z., Liu H. Current Mechanistic Insights into the Role of Infection in Systemic Lupus Erythematosus. Biomed. Pharmacother. 2019;117:109122. doi: 10.1016/j.biopha.2019.109122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2019.109122</ArticleId><ArticleId IdType="pubmed">31226637</ArticleId></ArticleIdList></Reference><Reference><Citation>Cainelli F., Vento S. Chapter 38&#x2014;Malaria and Systemic Lupus Erythematosus: Complex Interactions and Reciprocal Influences. In: Shoenfeld Y., Agmon-Levin N., Rose N.R., editors. Infection and Autoimmunity. 2nd ed. Academic Press; Amsterdam, The Netherlands: 2015. pp. 657&#x2013;668.</Citation></Reference><Reference><Citation>D&#xf6;rner T. Hydroxychloroquine in SLE: Old Drug, New Perspectives. Nat. Rev. Rheumatol. 2010;6:10&#x2013;11. doi: 10.1038/nrrheum.2009.235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2009.235</ArticleId><ArticleId IdType="pmc">PMC7097534</ArticleId><ArticleId IdType="pubmed">20046202</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf S.J., Estadt S.N., Theros J., Moore T., Ellis J., Liu J., Reed T.J., Jacob C.O., Gudjonsson J.E., Kahlenberg J.M. Ultraviolet Light Induces Increased T Cell Activation in Lupus-Prone Mice via Type I IFN-Dependent Inhibition of T Regulatory Cells. J. Autoimmun. 2019;103:102291. doi: 10.1016/j.jaut.2019.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.06.002</ArticleId><ArticleId IdType="pmc">PMC6708464</ArticleId><ArticleId IdType="pubmed">31248690</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X., Li F., Yang B., Liang J., Qin H., Xu J. Effects of Ultraviolet B Exposure on DNA Methylation in Patients with Systemic Lupus Erythematosus. Exp. Ther. Med. 2013;5:1219&#x2013;1225. doi: 10.3892/etm.2013.960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2013.960</ArticleId><ArticleId IdType="pmc">PMC3628076</ArticleId><ArticleId IdType="pubmed">23596493</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M., Kim M.Y., Kalunian K.C., Grossman J., Hahn B.H., Sammaritano L.R., Lockshin M., Merrill J.T., Belmont H.M., Askanase A.D., et al. Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus. N. Engl. J. Med. 2005;353:2550&#x2013;2558. doi: 10.1056/NEJMoa051135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa051135</ArticleId><ArticleId IdType="pubmed">16354891</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernier M., Mikaeloff Y., Hudson M., SuissA S. Combined Oral Contraceptive Use and the Risk of Systemic Lupus Erythematosus. Arthritis Care Res. 2009;61:476&#x2013;481. doi: 10.1002/art.24398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24398</ArticleId><ArticleId IdType="pubmed">19333988</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollard K.M. Silica, Silicosis, and Autoimmunity. Front. Immunol. 2016;7:97. doi: 10.3389/fimmu.2016.00097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00097</ArticleId><ArticleId IdType="pmc">PMC4786551</ArticleId><ArticleId IdType="pubmed">27014276</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown J.M., Archer A.J., Pfau J.C., Holian A. Silica Accelerated Systemic Autoimmune Disease in Lupus-Prone New Zealand Mixed Mice. Clin. Exp. Immunol. 2003;131:415&#x2013;421. doi: 10.1046/j.1365-2249.2003.02094.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.2003.02094.x</ArticleId><ArticleId IdType="pmc">PMC1808650</ArticleId><ArticleId IdType="pubmed">12605693</ArticleId></ArticleIdList></Reference><Reference><Citation>Speyer C.B., Costenbader K.H. Cigarette Smoking and the Pathogenesis of Systemic Lupus Erythematosus. Expert Rev. Clin. Immunol. 2018;14:481&#x2013;487. doi: 10.1080/1744666X.2018.1473035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2018.1473035</ArticleId><ArticleId IdType="pmc">PMC7069669</ArticleId><ArticleId IdType="pubmed">29724134</ArticleId></ArticleIdList></Reference><Reference><Citation>Costenbader K.H., Kim D.J., Peerzada J., Lockman S., Nobles-Knight D., Petri M., Karlson E.W. Cigarette Smoking and the Risk of Systemic Lupus Erythematosus: A Meta-Analysis. Arthritis Rheumatol. 2004;50:849&#x2013;857. doi: 10.1002/art.20049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.20049</ArticleId><ArticleId IdType="pubmed">15022327</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang F., Li S., Jia C. Smoking and the Risk of Systemic Lupus Erythematosus: An Updated Systematic Review and Cumulative Meta-Analysis. Clin. Rheumatol. 2015;34:1885&#x2013;1892. doi: 10.1007/s10067-015-3008-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-015-3008-9</ArticleId><ArticleId IdType="pubmed">26188616</ArticleId></ArticleIdList></Reference><Reference><Citation>Solhjoo M., Goyal A., Chauhan K. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2022. Drug-Induced Lupus Erythematosus.</Citation><ArticleIdList><ArticleId IdType="pubmed">28722919</ArticleId></ArticleIdList></Reference><Reference><Citation>Bataille P., Lebrun-Vignes B., Tubach F., Aroux-Pavard M., Philibert C., Chasset F., Barbaud A. Proton Pump Inhibitors Associated With Drug-Induced Lupus Erythematosus. JAMA Dermatol. 2022;158:1208&#x2013;1210. doi: 10.1001/jamadermatol.2022.2421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamadermatol.2022.2421</ArticleId><ArticleId IdType="pmc">PMC9386607</ArticleId><ArticleId IdType="pubmed">35976639</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y., Sawalha A.H. Drug-Induced Lupus Erythematosus: An Update on Drugs and Mechanisms. Curr. Opin. Rheumatol. 2018;30:490. doi: 10.1097/BOR.0000000000000522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000522</ArticleId><ArticleId IdType="pmc">PMC7299070</ArticleId><ArticleId IdType="pubmed">29870500</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>